TerminatedNot Applicable

SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus

Stopped: COVID-19

Canada10 participantsStarted 2019-07-15

Plain-language summary

The purpose of this study is to determine whether transcranial direct current stimulation affects super refractory status epilepticus.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of super refractory status epilepticus * admitted to the intensive care unit * identifiable epileptogenic focus on EEG Exclusion Criteria: * contraindications to scalp EEG * lice * scabies * other hair/skin infection * scalp psoriasis * hypersensitivity * other severe dermatological condition * previous adverse reaction to collodion * vagal nerve stimulator * implantable cardioverter defibrillator * cardiac pacemaker

What they're measuring

Frequency of Epileptiform Activity, Per Patient-based

Timeframe: Up to 3 hours per EEG recording

Trial details

NCT IDNCT03819543

SponsorUniversity of Manitoba

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-11-30

Results submitted2022-11-01

View on ClinicalTrials.gov More Status Epilepticus trials